Cadralazine

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.[1]

Cadralazine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • Ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H21N5O3
Molar mass283.332 g·mol−1
3D model (JSmol)
SMILES
  • O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1
InChI
  • InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) N
  • Key:QLTVVOATEHFXLT-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

References
  1. McTavish D, Young RA, Clissold SP (October 1990). "Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension". Drugs. 40 (4): 543–60. doi:10.2165/00003495-199040040-00005. PMID 2083513.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.